A nasal spray company wants to make it harder for the FTC to police health claims

In the midst of the covid-19 pandemic, a wellness products institution called Xlear began advertizing its saline nasal spray to radical desperately searching for ways to support themselves from a caller virus. In its marketing, Xlear pointed to studies that it said supported the thought that ingredients successful the spray could artifact viruses from sticking to the nasal cavity. Based connected its mentation of the science, Xlear promoted the merchandise arsenic 1 portion of a "layered defense" against contracting covid.

In 2021, the Federal Trade Commission, successful a bipartisan vote, decided to writer Xlear for making allegedly "unsupported wellness claims," saying the institution had "grossly misrepresented the purported findings and relevance of respective technological studies" successful its advertising. Earlier this year, the Trump Justice Department, connected the FTC's behalf, asked for the suit to beryllium dismissed with prejudice, though it didn't explicate its reasoning. But Xlear inactive wanted its time successful court. Now, it's suing the FTC due to the fact that it wants a tribunal to marque it harder for the bureau to effort to spell aft wellness claims.

Xlear is filing the suit astatine a clip wherever the government's modular operating procedures astir some subject a …

Read the afloat communicative astatine The Verge.